DorisGay YeeLeungMDPhD

Clinical Trials

• Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy Start of enrollment: 2012 Mar 01

  Active, not recruiting

• Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy Start of enrollment: 2014 Nov 01

  Completed

  Phase 2

• A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy Start of enrollment: 2014 Nov 24

  Terminated

  Phase 2

• A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 Start of enrollment: 2014 Dec 01

  Completed

  Phase 1, Phase 2

• Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy Start of enrollment: 2015 Jun 30

  Completed

  Phase 2

• Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD Start of enrollment: 2015 Dec 02

  Terminated

  Phase 1, Phase 2

• Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients Start of enrollment: 2015 Oct 08

  Completed

  Phase 1

• Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) Start of enrollment: 2015 Nov 30

  Completed

  Phase 1, Phase 2

• A Trial of PF-06252616 in Ambulatory Participants With LGMD2I Start of enrollment: 2016 Jul 01

  Completed

  Phase 1, Phase 2

• Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) Start of enrollment: 2023 May 31

  Recruiting

  Phase 3

  Roles: Contact, Principal Investigator

• A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1) Start of enrollment: 2023 Mar 12

  Recruiting

  Phase 1, Phase 2

• Defining Endpoints in Becker Muscular Dystrophy Start of enrollment: 2022 Apr 13

  Recruiting

• Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) Start of enrollment: 2019 Jun 14

  Recruiting

• Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Start of enrollment: 2020 Oct 19

  Recruiting

  Phase 2

• Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) Start of enrollment: 2020 Dec 15

  Recruiting

• Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD Start of enrollment: 2018 Mar 05

  Active, not recruiting

• Biomarker Development in LGMD2i Start of enrollment: 2019 Dec 01

  Completed

• Join now to see all